- Allison Samuel
- Philip Nguyen
Pharmacy Grand Rounds Interactive Lunch and Learn (GRILL) is a forum for educational presentations by pharmacy residents and residency track pharmacy students in their final year of school delivered to a group of seasoned pharmacists, pharmacy residents, and pharmacy students. A focus of the activity will be on interactive learning that engages the in person as well as a remote live audience.
Primarily for pharmacists and pharmacy students
Also pertinent for physicians, medical students, nurse practitioners, pharmacy technicians, and physicians assistants
Dave Hager, PharmD, Chair
Allison Samuel, PharmD, Coordinator
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 1.0 hours of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion.
2020 Universal Activity Number (UAN): JA0000358-0000-20-116-L01-P
General Pharmacy UAN: JA0000358-0000-20-124-L04-P
2021 Universal Activity Number (UAN) JA0000358-0000-21-044-L01-P
Compounding UAN: JA0000358-0000-21-095-L07-P
2022 Universal Activity Number (UAN)
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1.0 hours.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational activity, learners will be able to:
1. Grow overall pharmacotherapy knowledge-base.
2. Enhance ability to analyze patient cases, published research literature, and/or guideline recommendations.
3. Create appropriate pharmacotherapy plans based on evidence based medicine, clinical decision making, and logistical considerations.